Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare morphologic variant of well differentiated liposarcoma occurring most often in the retroperitoneum. It is characterized by the presence of a predominant inflammatory infiltrate composed of lymphoplasmacytic aggregates.
Biomarker and diagnostic research for inflammatory liposarcoma has been reported in the published literature.
No clinical trials have been registered for inflammatory liposarcoma.
6 publications have been identified in PubMed for inflammatory liposarcoma. Research spans Case Report / Case Series (67%), Diagnostic / Biomarker (17%), and Review / Meta-Analysis (17%).
Chen J (2025). [PMID: 39295172](https://pubmed.ncbi.nlm.nih.gov/39295172/). *Journal of clinical ultrasound : JCU*. [Case Report / Case Series]
Abel W (2025). [PMID: 40290567](https://pubmed.ncbi.nlm.nih.gov/40290567/). *Case reports in surgery*. [Case Report / Case Series]
Kawasaki T (2025). [PMID: 40444330](https://pubmed.ncbi.nlm.nih.gov/40444330/). *Journal of clinical ultrasound : JCU*. [Diagnostic / Biomarker]
Liu H (2025). [PMID: 40421219](https://pubmed.ncbi.nlm.nih.gov/40421219/). *Frontiers in pharmacology*. [Review / Meta-Analysis]
Zhao Q (2024). [PMID: 38598478](https://pubmed.ncbi.nlm.nih.gov/38598478/). *Clinical nuclear medicine*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:58 PM UTC